| Literature DB >> 31959794 |
Hyoeun Kim1, Sunmi Yoo2, Seung Guk Park1.
Abstract
Direct effects of cancer cells and various cancer treatments can cause bone loss in cancer survivors. The aim of this study was to assess the risk of bone loss in Korean cancer survivors, and the relationship between body composition and bone mineral density (BMD). We hypothesized that cancer survivors would have lower BMD than healthy people, and increased muscle mass has a protective effect on BMD. We measured BMD and body composition in 259 cancer survivors (99 men and 160 women). Subjects were selected from the Korean National Health and Nutrition Survey conducted from 2008 to 2011. Body composition and BMD were measured by dual-energy X-ray absorptiometry. We examined the linear trend of lumbar BMD according to tertiles of lean mass (LM) and fat mass (FM) by linear regression, adjusting for age, alcohol consumption, smoking, exercise, 25-hydroxyvitamin D, height, protein intake, and menopausal status. Cancer survivors under 50 years of age had lower lumbar BMD compared with healthy controls (0.93 ± 0.04 g/cm2 vs. 1.02 ± 0.01 g/cm2, p = 0.032 in males; 0.95 ± 0.02 g/cm2 vs. 0.98 ± 0.01 g/cm2, p = 0.015 in females). Lumbar BMD significantly increased from the lowest to highest tertiles of LM in male (p for trend < 0.001) and marginally significantly increased in female survivors (p for trend = 0.060). In this study of Korean cancer survivors, young survivors were at higher risk of having low lumbar BMD. Higher LM had beneficial effects on BMD in cancer survivors. To prevent osteoporosis and fractures, efforts to increase lean body mass, including bone, are needed for young cancer survivors.Entities:
Mesh:
Year: 2020 PMID: 31959794 PMCID: PMC6971234 DOI: 10.1038/s41598-020-57503-y
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Clinical characteristics of cancer survivors and sex- and age- matched healthy controls.
| Male | Female | |||||
|---|---|---|---|---|---|---|
| Cancer survivors | Healthy controls | p | Cancer survivors | Healthy controls | p-value | |
| Age (years) | 58.13 ± 1.89 | 57.11 ± 0.96 | 0.621 | 49.05 ± 0.96 | 49.03 ± 0.42 | 0.989 |
| Rural residence (%) | 31.6 | 33.9 | 0.704 | 29.3 | 26.4 | 0.466 |
| Duration of education ≤9 years (%) | 42.1 | 46.7 | 0.486 | 36.1 | 37.2 | 0.812 |
| Low income (%) | 26.5 | 23.7 | 0.640 | 24.9 | 21.5 | 0.420 |
| Heavy drinking (%) | 33.2 | 47.2 | 0.039 | 8.9 | 17.4 | 0.024 |
| Physical inactivity (%) | 43.5 | 42.5 | 0.892 | 48.7 | 46.6 | 0.696 |
| Currently smoke cigarettes (%) | 28.4 | 52.2 | 0.003 | 2.8 | 7.1 | 0.110 |
| Have family history of fracture (%) | 8.7 | 13.1 | 0.216 | 22.4 | 20.5 | 0.637 |
| Prior fragility fracture (%) | 15.0 | 9.0 | 0.252 | 3.1 | 5.5 | 0.311 |
| Body mass index (kg/m2) | 22.76 ± 0.29 | 23.28 ± 0.15 | 0.104 | 23.46 ± 0.44 | 23.27 ± 0.12 | 0.671 |
| Lean mass (kg) | 45.50 ± 0.75 | 46.84 ± 0.37 | 0.099 | 34.38 ± 0.40 | 34.08 ± 0.17 | 0.485 |
| Fat mass (kg) | 16.34 ± 0.48 | 16.21 ± 0.18 | 0.794 | 18.07 ± 0.64 | 18.06 ± 0.20 | 0.991 |
| ALP (IU/L) | 264.65 ± 8.61 | 234.58 ± 3.18 | 0.001 | 244.25 ± 8.88 | 213.45 ± 3.17 | 0.001 |
| 25-Hydroxyvitamin D (ng/mL) | 18.88 ± 0.91 | 20.71 ± 0.50 | 0.080 | 18.05 ± 0.68 | 17.09 ± 0.29 | 0.178 |
| Total calorie intake (kcal/day) | 2036.76 ± 119.17 | 2211.22 ± 48.50 | 0.169 | 1675.68 ± 60.65 | 1662.67 ± 27.84 | 0.847 |
| Total protein intake (g/day) | 70.70 ± 4.84 | 77.36 ± 2.39 | 0.213 | 59.17 ± 2.75 | 58.99 ± 1.10 | 0.950 |
| Total calcium intake (mg/day) | 578.86 ± 52.77 | 519.24 ± 23.59 | 0.307 | 511.12 ± 38.38 | 463.21 ± 12.74 | 0.239 |
| Postmenopausal (%) | NA | NA | NA | 66.6 | 45.3 | <0.001 |
Numbers were showed as absolute numbers before the weighting. Data were expressed as the estimated means ± standard error or estimated percentage. P-values were for the chi-square test for categorical variables and t-test for continuous variables. A p- value of less than 0.05 was considered as statistically significant
Abbreviations: ALP, alkaline phosphatase; NA, not applicable;
Age-adjusted characteristics of bone health at various sites by aged 50 years or older in men.
| Young (<50 years) | Old (≥50 years) | |||||
|---|---|---|---|---|---|---|
| Cancer survivors | Healthy comparison | p | Cancer survivors | Healthy comparison | p | |
| Femur neck BMD (g/cm2) | 0.83 ± 0.04 | 0.88 ± 0.01 | 0.179 | 0.72 ± 0.02 | 0.73 ± 0.01 | 0.351 |
| Total femur BMD (g/cm2) | 0.97 ± 0.04 | 1.01 ± 0.01 | 0.234 | 0.89 ± 0.01 | 0.91 ± 0.01 | 0.188 |
| Lumbar spine BMD (g/cm2) | 0.93 ± 0.04 | 1.02 ± 0.01 | 0.032 | 0.90 ± 0.02 | 0.93 ± 0.01 | 0.072 |
| Femur neck T-score | −0.28 ± 0.29 | 0.29 ± 0.11 | 0.059 | −1.03 ± 0.12 | −0.91 ± 0.05 | 0.351 |
| Total femur T-score | 0.06 ± 0.21 | 0.45 ± 0.08 | 0.083 | −0.37 ± 0.10 | −0.23 ± 0.04 | 0.188 |
| Lumbar spine T-score | −0.81 ± 0.28 | −0.10 ± 0.11 | 0.020 | −1.06 ± 0.12 | −0.81 ± 0.07 | 0.072 |
Numbers were showed as absolute numbers before the weighting. Data were expressed as the estimated means ± standard error. The t-test was used for comparing two groups of continuous data. A p- value of less than 0.05 was considered as statistically significant.
Abbreviations: BMD, bone mineral density.
Age-adjusted characteristics of bone health at various sites by aged 50 years or older in women.
| Young (<50 years) | Old (≥50 years) | |||||
|---|---|---|---|---|---|---|
| Cancer survivors | Healthy comparison | p | Cancer survivors | Healthy comparison | p | |
| Femur neck BMD (g/cm2) | 0.74 ± 0.01 | 0.75 ± 0.01 | 0.452 | 0.66 ± 0.01 | 0.66 ± 0.01 | 0.653 |
| Total femur BMD (g/cm2) | 0.89 ± 0.01 | 0.90 ± 0.01 | 0.530 | 0.80 ± 0.01 | 0.81 ± 0.01 | 0.248 |
| Lumbar spine BMD (g/cm2) | 0.95 ± 0.02 | 0.98 ± 0.01 | 0.015 | 0.81 ± 0.02 | 0.83 ± 0.01 | 0.306 |
| Femur neck T-score | −0.56 ± 0.12 | −0.46 ± 0.05 | 0.461 | −1.37 ± 0.10 | −1.32 ± 0.05 | 0.653 |
| Total femur T-score | 0.34 ± 0.12 | 0.40 ± 0.06 | 0.656 | −0.48 ± 0.11 | −0.34 ± 0.05 | 0.248 |
| Lumbar spine T-score | −0.53 ± 0.13 | −0.20 ± 0.06 | 0.015 | −1.72 ± 0.14 | −1.56 ± 0.07 | 0.306 |
Numbers were showed as absolute numbers before the weighting. Data were expressed as the estimated means ± standard error. The t-test was used for comparing two groups of continuous data. A p- value of less than 0.05 was considered as statistically significant.
Abbreviations: BMD, bone mineral density.
Lumbar spine bone mineral density (BMD) according to group specific tertiles of lean mass or fat mass.
| Lean mass* | First tertile | Second tertile | Third tertile (range, kg) | P for trend |
|---|---|---|---|---|
| Men, cancer survivor | (32.68–41.75) | (42.03–46.79) | (47.01–57.03) | |
| Fully adjusted (g/cm2) | 0.82 ± 0.03 | 0.96 ± 0.02 | 0.97 ± 0.03 | <0.001 |
| Men, healthy | (28.24–42.70) | (42.75–47.92) | (47.94–74.35) | |
| Fully adjusted (g/cm2) | 0.87 ± 0.02 | 0.95 ± 0.02 | 0.99 ± 0.02 | <0.001 |
| Women, cancer survivor | (23.96–31.91) | (31.95–35.27) | (35.28–53.12) | |
| Fully adjusted (g/cm2) | 0.95 ± 0.04 | 0.97 ± 0.03 | 1.02 ± 0.04 | 0.060 |
| Women, healthy | (19.04–31.73) | (31.74–35.41) | (35.45–53.64) | |
| Fully adjusted (g/cm2) | 0.88 ± 0.01 | 0.88 ± 0.01 | 0.90 ± 0.01 | 0.249 |
| Fat mass† | First tertile (range, kg) | Second tertile (range, kg) | Third tertile (range, kg) | P for trend |
| Men, cancer survivor | (3.58–10.36) | (10.75–14.73) | (14.88–25.80) | |
| Fully adjusted (g/cm2) | 0.85 ± 0.03 | 0.91 ± 0.03 | 0.98 ± 0.03 | 0.019 |
| Men, healthy | (2.96–10.88) | (10.90–14.63) | (14.66–39.91) | |
| Fully adjusted (g/cm2) | 0.96 ± 0.02 | 0.94 ± 0.02 | 0.95 ± 0.01 | 0.855 |
| Women, cancer survivor | (4.19–14.80) | (14.92–19.37) | (19.46–38.64) | |
| Fully adjusted (g/cm2) | 0.98 ± 0.04 | 0.94 ± 0.04 | 0.98 ± 0.03 | 0.171 |
| Women, healthy | (4.23–15.60) | (15.62–19.46) | (19.51–39.91) | |
| Fully adjusted (g/cm2) | 0.85 ± 0.01 | 0.89 ± 0.01 | 0.92 ± 0.01 | <0.001 |
Data were expressed as the estimated means ± standard error. *Adjusted for fat mass, drinking, smoking, exercise, 25(OH)D (ng/mL), height (m), daily protein intake (g/day), age groups (<50 or ≥50 years) and menopausal status (pre- or postmenopausal, in women). †Adjusted for lean mass, drinking, smoking, exercise, 25(OH)D (ng/mL), height (m), daily protein intake (g/day), age groups (<50 or ≥50 years) and menopausal status (pre- or postmenopausal, in women).